SAREPTA THERAPEUTICS INC COM USD0.0001 revenue breakdown overview

SAREPTA THERAPEUTICS INC COM USD0.0001 revenue for the last year amounted to 1.90 B USD, the most of which — 1.79 B USD — came from its highest performing source at the moment, RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities, the year earlier bringing 1.14 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought SAREPTA THERAPEUTICS INC COM USD0.0001 1.64 B USD, and the year before that — 998.30 M USD.